ReviewAllergy and asthma proceedings2024
Hereditary angioedema with normal C1 esterase inhibitor: Current paradigms and clinical dilemmas.
Review in Allergy and asthma proceedings, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Communication, characterization, personalization, and clinical reasoning: The four pillars of modern allergy practice.Allergy and asthma proceedings · 2026Article
- Food allergy, biologic therapies, and diagnostic precision: Expanding frontiers in allergy and immunology.Allergy and asthma proceedings · 2026Article
- From molecular pathways to meaningful patient management: Navigating complexity in allergy and immunology.Allergy and asthma proceedings · 2026Article
- Treatment of Hereditary Angioedema With Plasma-Derived C1 Inhibitor: A Review.Clinical and translational allergy · 2025Review
- C1 esterase inhibitor (C1-INH) response as a supportive diagnostic criterion for patients with suspected hereditary angioedema with normal C1-INH.The World Allergy Organization journal · 2025Article
- Hereditary Angioedema With Normal C1 Esterase Inhibitor: A Case of a Late Diagnosis in a 48-Year-Old Male.Cureus · 2025Article
- Artificial intelligence and allergy: Shaping the future of diagnosis and therapy.Allergy and asthma proceedings · 2025Article
- Hereditary angioedema diagnosis: Reflecting on the past, envisioning the future.The World Allergy Organization journal · 2025Review
- From burden to breakthrough: Advances in hereditary angioedema, drug allergy, and allergic disease prevention.Allergy and asthma proceedings · 2025Article
- Exploring mast cell disorders: Tryptases, hereditary alpha-tryptasemia, and MCAS treatment approaches.Allergy and asthma proceedings · 2025Article
- Erratum: Effect of Fresh Frozen Plasma Infusion on Hospital Length of Stay for Patients With Hereditary Angioedema.Journal of health economics and outcomes research · 2025Article
- Perspectives on allergic diseases: From asthma to food allergy - A continuing challenge for the Allergist-Immunologist.Allergy and asthma proceedings · 2024Article
- Exploring the spectrum of allergic disorders that continue to challenge the Allergist-Immunologist: From hereditary angioedema to metal implant allergy.Allergy and asthma proceedings · 2024Article
Corrections and comments
- Commented on by
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
38755781What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.